COMMON LESIONS OF THE ORAL CAVITY

oralcavitykapak

ERYTHROPLAKIA

Mehmet Akyüz1
Güldane Mağat2

1Denizli Oral and Dental Health Hospital, Department of Oral and Maxillofacial Radiology, Denizli, Türkiye
2Necmettin Erbakan University Faculty of Dentistry, Department of Oral and Maxillofacial Radiology, Konya, Türkiye

ABSTRACT

Erythroplakia are red lesions on the oral mucosa and other mucosal surfaces that have no known cause or cannot be classified into a specific lesion group, such as inflammatory erythema and red lesions caused by vascular anomalies. The World Health Organization (WHO) defines erythroplakia as red plaque-like lesions on the oral mucosa that do not correspond to any clinically or pathologically known entity. Oral erythroplakia has a very low incidence compared to leukoplakia. Nevertheless, it ranks second in frequency among precancerous lesions and is considered the most likely lesion to undergo malignant transformation. The most common sites of erythroplakia are the soft palate, dorsum of the tongue, floor of the mouth and tonsils. These lesions are usually asymptomatic and unilocular. Because of the high rate of malignant transformation, erythroplakia requires careful evaluation for accurate diagnosis and treatment. Early diagnosis of erythroplakia is critical for the prevention of oral cancers.

Keywords: Erythroplakia; Oral mucosa; Oral cancer

Referanslar

  1. Shafer WG, Hine MK, Levy BM. A textbook of oral pathology. A textbook of oral pathology1963:xv, 768-xv, 768.
  2. Amagasa TJIjoco. Oral premalignant lesions. 2011;16:1-4. [Crossref]  [PubMed]
  3. Wood NK, Goaz PW. Differential Diagnosis of Oral Lesions. Mosby; 1985.
  4. Vedtofte P, Holmstrup P, Hjørting-Hansen E, Pindborg JJIjoo, surgery m. Surgical treatment of premalignant lesions of the oral mucosa. 1987;16(6):656-664. [Crossref]  [PubMed]
  5. Scully C. Oral and maxillofacial medicine: the basis of diagnosis and treatment. Elsevier Health Sciences; 2013. [Crossref]
  6. Wetzel SL, Wollenberg JJDCoNA. Oral Potentially Malignant Disorders. 2020;64(1):25-37. [Crossref]  [PubMed]
  7. Gendelman H, Actis A, Ouri HJAsB. Neodymium-YAG and CO2 lasers in treatment of pre-cancerous lesions of the oral cavity. 1993;90(2):95-101.
  8. Shear MJIDJ. Erythroplakia of the mouth. 1972;22(4):460-473.
  9. Shafer WG, Waldron CAJC. Erythroplakia of the oral cavity. 1975;36(3):1021-1028. [Crossref]  [PubMed]
  10. Hashibe M, Mathew B, Kuruvilla B, et al. Chewing tobacco, alcohol, and the risk of erythroplakia. 2000;9(7):639-645.
  11. McCullough M, Prasad G, Farah CJAdj. Oral mucosal malignancy and potentially malignant lesions: an update on the epidemiology, risk factors, diagnosis and management. 2010;55:61-65. [Crossref]  [PubMed]
  12. Regezi JA, Sciubba J, Jordan RCK. Oral Pathology: Clinical Pathologic Correlations. Elsevier Health Sciences; 2016.
  13. van der Waal IJOo. Potentially malignant disorders of the oral and oropharyngeal mucosa; present concepts of management. 2010;46(6):423-425. [Crossref]  [PubMed]
  14. Villa A, Villa C, Abati SJAdj. Oral cancer and oral erythroplakia: an update and implication for clinicians. 2011;56(3):253-256. [Crossref]  [PubMed]
  15. Hashibe M, Jacob B, Thomas G, et al. Socioeconomic status, lifestyle factors and oral premalignant lesions. 2003;39(7):664-671. [Crossref]  [PubMed]
  16. Jacob BJ, Straif K, Thomas G, et al. Betel quid without tobacco as a risk factor for oral precancers. 2004;40(7):697-704. [Crossref]  [PubMed]
  17. Thomas G, Hashibe M, Jacob BJ, et al. Risk factors for multiple oral premalignant lesions. 2003;107(2):285-291. [Crossref]  [PubMed]
  18. Haghshenas MR, Moosazadeh M, Taghiloo S, Sattari S, Valadan R, Mousavi T. Association Between Human Papillomavirus and Oral Cancer in Iranian Clinical Samples: A Meta-Analysis Review. Iranian Journal of Public Health. 2022. [Crossref]  [PubMed]  [PMC]
  19. Syrjänen S, Lodi G, Bültzingslöwen Iv, et al. Human Papillomaviruses in Oral Carcinoma and Oral Potentially Malignant Disorders: A Systematic Review. Oral Diseases. 2011;17(s1):58-72. [Crossref]  [PubMed]
  20. Yete S, D'Souza W, Saranath D. High-Risk Human Papillomavirus in Oral Cancer: Clinical Implications. Oncology. 2017;94(3):133-141. [Crossref]  [PubMed]
  21. Zendeli-Bedjeti L, Poposkova M, Atanasovska-Stojanovska A, Duvlis S. Human Papillomavirus as a Potential Risk Factor for Oral Premalignant Lesions. Acta Clinica Croatica. 2017. [Crossref]  [PubMed]
  22. Mousavi T, Mosazadeh M, Taghiloo S, Valadan R, Sattari S, Haghshenas MR. Association Between Human Papillomavirus and Oral Cancer in Iranian Clinical Samples: A MetaAnalysis Review. 2021. [Crossref]
  23. Patait M, Nikate U, Saraf K, Singh P, Jadhav VJIJADS. Oral erythroplakia-A case report. 2016;2(4):79-82.
  24. Lavelle CL, Proctor DBJ. Clinical pathology of the oral mucosa. 1978.
  25. Al Maweri SA, Abbas A, Tarakji B, Al-Jamaei AS, Alaizari NA, Al-Shamiri HM. Knowledge and Opinions Regarding Oral Cancer Among Yemeni Dental Students. Asian Pacific Journal of Cancer Prevention. 2015;16(5):1765-1770. [Crossref]  [PubMed]
  26. Holmstrup P. Oral Erythroplakia-What Is It? Oral Diseases. 2018;24(1-2):138-143. [Crossref]  [PubMed]
  27. Sreelatha SV, Chuppa S, Bharati DB, Chowdhury CR, Shetty P. Leukoplakia and Erythroplakia: A Clinicians Perspective and Histopathologist Verdict - A Retrospective Study. Journal of Advanced Clinical and Research Insights. 2016;3(4):143-146. [Crossref]
  28. Yang SW, Lee YS, Chang LC, Hwang CC, Luo C, Chen T-A. Clinical Characteristics of Narrow-Band Imaging of Oral Erythroplakia and Its Correlation With Pathology. BMC Cancer. 2015;15(1). [Crossref]  [PubMed]  [PMC]
  29. Sharma V, Bandyopadhyay S, Sikka K, Kakkar A, Hariprasad G, Singh SB. Label-Free Proteomics of Oral Mucosa Tissue to Identify Potential Biomarkers That Can Flag Predilection of Precancerous Lesions to Oral Cell Carcinoma: A Preliminary Study. Disease Markers. 2023;2023:1-16. [Crossref]  [PubMed]  [PMC]
  30. Magdum DB, Kulkarni NA, Kavle PG, Paraye S, Pohankar PS, Giram AV. Salivary Neutrophil-to-Lymphocyte Ratio as a Prognostic Predictor of Oral Premalignant and Malignant Disorders: A Prospective Study. Cureus. 2024. [Crossref]
  31. Hosni ES, Salum FG, Cherubini K, Yurgel LS, Figueiredo MAZd. Oral Erythroplakia and Speckled Leukoplakia: Retrospective Analysis of 13 Cases. Brazilian Journal of Otorhinolaryngology. 2009;75(2):295-299. [Crossref]  [PubMed]
  32. World Health Organization IAfRoC, Oral Atlas [Internet]. [cited 2017] Available from: [Link] .
  33. Maymone MB, Greer RO, Kesecker J, et al. Premalignant and malignant oral mucosal lesions: Clinical and pathological findings. 2019;81(1):59-71. [Crossref]  [PubMed]  [PMC]
  34. Qin GZ, Park JY, Chen SY, Lazarus PJIjoc. A high prevalence of p53 mutations in pre malignant oral erythroplakia. 1999;80(3):345-348. [Crossref]
  35. Mendes SF, Ramos GdO, Rivero ERC, Modolo F, Grando LJ, Meurer MIJJoo. Techniques for precancerous lesion diagnosis. 2011;2011(1):326094. [Crossref]  [PubMed]  [PMC]
  36. Cancela Rodríguez P, Cerero Lapiedra R, Esparza Gómez G, Llamas Martínez S, Warnakulasuriya SJJoop, medicine. The use of toluidine blue in the detection of pre malignant and malignant oral lesions. 2011;40(4):300-304. [Crossref]  [PubMed]
  37. Mehrotra R, Gupta DKJH, oncology n. Exciting new advances in oral cancer diagnosis: avenues to early detection. 2011;3:1-9. [Crossref]  [PubMed]  [PMC]
  38. Anggarista KAN, Datau MA, Mahdani FY, Radithia D, Ernawati DS, Surboyo MDC. Knowledge of Dental Students About Erythroplakia as an Oral Potentially Malignant Disorder. Journal of Health and Allied Sciences Nu. 2023;14(03):355-359. [Crossref]
  39. Rabinovici-Cohen S, Fridman N, Weinbaum M, et al. From Pixels to Diagnosis: Algorithmic Analysis of Clinical Oral Photos for Early Detection of Oral Squamous Cell Carcinoma. Cancers. 2024;16(5):1019. [Crossref]  [PubMed]  [PMC]
  40. Warnakulasuriya S, Kujan O, Aguirre Urízar JM, et al. Oral Potentially Malignant Disorders: A Consensus Report From an International Seminar on Nomenclature and Classification, Convened by the WHO Collaborating Centre for Oral Cancer. Oral Diseases. 2020;27(8):1862-1880. [Crossref]  [PubMed]
  41. Mazur M, Ndokaj A, Venugopal DC, et al. In Vivo Imaging-Based Techniques for Early Diagnosis of Oral Potentially Malignant Disorders-Systematic Review and Meta-Analysis. International Journal of Environmental Research and Public Health. 2021;18(22):11775. [Crossref]  [PubMed]  [PMC]
  42. Swain SK. Premalignant Lesions of the Oral Cavity: Current Perspectives. International Journal of Research in Medical Sciences. 2021;9(6):1816. [Crossref]
  43. None N, Pandey A. Cryotherapy for Oral Potentially Malignant Disorders. Bioinformation. 2023;19(13):1377-1382. [Crossref]  [PubMed]  [PMC]
  44. Gondivkar S, Gadbail AR, Choudhary MG, Vedpathak PR, Likhitkar MS. Photodynamic Treatment Outcomes of Potentially malignant Lesions and Malignancies of the Head and Neck Region: A Systematic Review. Journal of Investigative and Clinical Dentistry. 2017;9(1). [Crossref]  [PubMed]
  45. Dionne KR, Warnakulasuriya S, Zain RB, Cheong SC. Potentially Malignant Disorders of the Oral Cavity: Current Practice and Future Directions in the Clinic and Laboratory. International Journal of Cancer. 2014;136(3):503-515. [Crossref]  [PubMed]
  46. Scheer M, Neugebauer J, Derman A, et al. Autofluorescence imaging of potentially malignant mucosa lesions. 2011;111(5):568-577. [Crossref]  [PubMed]
  47. Reichart PA, Philipsen HPJOo. Oral erythroplakia-a review. 2005;41(6):551-561. [Crossref]  [PubMed]
  48. Ekiz ÖJTMJoMKU. Epitelyal Prekanseröz Lezyonlar/Epithelial Precancerous Lesions. 2016;7(28):46-55. [Crossref]
  49. Warnakulasuriya SJOs, oral medicine, oral pathology, radiology o. Clinical features and presentation of oral potentially malignant disorders. 2018;125(6):582-590. [Crossref]  [PubMed]
  50. Lorenzo-Pouso AI, Mendoza ILId, Pérez Sayáns M, et al. Critical Update, Systematic Review, and Meta analysis of Oral Erythroplakia as an Oral Potentially Malignant Disorder. Journal of Oral Pathology and Medicine. 2022;51(7):585-593. [Crossref]  [PubMed]  [PMC]
  51. Maia HCdM, Pinto NAS, Pereira JdS, Medeiros AMCd, Silveira ÉJDd, Miguel MCdC. Potentially Malignant Oral Lesions: Clinicopathological Correlations. Einstein (São Paulo). 2016;14(1):35-40. [Crossref]  [PubMed]  [PMC]
  52. Heidari AE, Sunny S, James BL, et al. Optical Coherence Tomography as an Oral Cancer Screening Adjunct in a Low Resource Settings. Ieee Journal of Selected Topics in Quantum Electronics. 2019;25(1):1-8. [Crossref]
  53. Patil AP, Yogeshkumar S. Tobacco Use and Oral Premalignant Lesions Among Auto-Rickshaw Drivers in Belagavi, North Karnataka. Indian Journal of Occupational and Environmental Medicine. 2023;27(1):79. [Crossref]  [PubMed]  [PMC]
  54. Carnelio S, Rodrigues G, Shenoy R, Fernandes DJ. A Brief Review of Common Oral Premalignant Lesions With Emphasis on Their Management and Cancer Prevention. Indian Journal of Surgery. 2011;73(4):256-261. [Crossref]  [PubMed]  [PMC]
  55. Yardımcı G, Kutlubay Z, Engın B, Tüzün Y. Precancerous Lesions of Oral Mucosa. World Journal of Clinical Cases. 2014;2(12):866. [Crossref]  [PubMed]  [PMC]
  56. Jerjes W, Upile T, Hamdoon Z, Mosse CA, Akram S, Hopper C. Photodynamic Therapy Outcome for Oral Dysplasia. Lasers in Surgery and Medicine. 2011;43(3):192-199. [Crossref]  [PubMed]
  57. Calero C, Garcés KMV, Sanchez WIM, Kassis EN. Bucomaxillofacial Cancer and Major Considerations and Treatments: A Concise Systematic Review. Mednext Journal of Medical and Health Sciences. 2022;3(2). [Crossref]
  58. Iriti M, Varoni EM. Chemopreventive Potential of Flavonoids in Oral Squamous Cell Carcinoma in Human Studies. Nutrients. 2013;5(7):2564-2576. [Crossref]  [PubMed]  [PMC]
  59. Warnakulasuriya S, Cain N. Screening for Oral Cancer: Contributing to the Debate. Journal of Investigative and Clinical Dentistry. 2011;2(1):2-9. [Crossref]  [PubMed]